Bone Marrow-sparing Intensity Modulated Radiation Therapy With Concurrent Cisplatin for Stage IB-IVA Cervical Cancer: An International Multicenter Phase 2 Clinical Trial (INTERTECC-2) Reply
2017
Abstract
Our research sought to determine whether varying pelvic radiation dose might improve outcomes for patients udergoing chemoradiotherapy. Positron emission tomography, intensity modulated radiation therapy, and image-guided radiation therapy are tools to understand the radiation effects on tissue function, but there are myriad reasons to invest in these technologies outside the narrow application for sparing bowel and bone marrow.